Digitek Manufacturer Issues Yet Another Major Recall
Actavis Totowas LLC., manufacturer of the recalled defective heart drug Digitek, has announced a voluntary recall of all drug products manufactured in its Little Falls, NJ facility. According to an alert posted by the U.S. Food and Drug Administration, the drug manufacturer took this action after an inspection conducted by the FDA earlier this year, found the conditions at the facility to be less than satisfactory.
Hundreds of heart patients around the country have filed complaints against Actavis alleging that its heart drug, Digitek, also known as Digoxin, caused severe side effects because of its dangerous drug dosage. The company recalled the drug after finding out that the tablets contained twice the approved level of the active ingredient.
We have a number of clients who have suffered serious side effects as a result of this defective drug. We are in the process of gathering the medical evidence to support their pharmaceutical litigation cases before filing our own lawsuits. An overdose of this drug, which is normally used to treat heart conditions, may cause nausea, vomiting, dizziness, high blood pressure, cardiac instability or even death. The most recent drug recall includes all products manufactured at that facility that have been supplied to retail outlets, wholesalers and hospitals.
Although this recent medical product recall is not connected with the Digitek recall, it clearly shows that the drug manufacturer has had a serious problem with quality control issues. They are already facing a number of lawsuits as a result of their negligence and failure to comply with federal safety standards.
If you or a loved one has suffered adverse reactions as a result of taking Digitek and would like to be kept advised of further developments or discuss your legal options, please call my office. We will answer your questions and put you on a list to update you with information.
